Literature DB >> 8764352

Inhibitory transmission in guinea pig stomach mediated by distinct receptors for pituitary adenylate cyclase-activating peptide.

S Katsoulis1, W E Schmidt, R Schwarzhoff, U R Folsch, J G Jin, J R Grider, G M Makhlouf.   

Abstract

Previous studies have shown that inhibitory transmission in guinea pig stomach involves an interplay between vasoactive intestinal peptide (VIP) and nitric oxide (NO). The present study examined the contribution of pituitary adenylate cyclase-activating peptide (PACAP), a homologous peptide present in gastric and intestinal myenteric neurons. VIP, PACAP-27 and PACAP-38 induced concentration-dependent relaxation that was partly inhibited by the antagonists VIP10-28 and PACAP6-38 and the NO synthase inhibitor NG-nitro-L-arginine (L-NNA). Only relaxation induced by PACAP-27 and PACAP-38 was partly inhibited by apamin. Electrical field stimulation (0.25-16 Hz) induced frequency-dependent relaxation and PACAP release (maximum of 35.7 fmol/100 mg-min or 7-fold above basal levels). Electrical field stimulation-induced relaxation was partly inhibited by a combination of selective monoclonal antibodies to PACAP-27 and PACAP-38 (42 +/- 7% at 16 Hz) and by the antagonists VIP10-28 (29 +/- 9%) and PACAP6-38 (29 +/- 3%). The relaxation was also partly inhibited by L-NNA (51 +/- 12% at 16 Hz) and apamin (36 +/- 4%). The effects of a combination of apamin and L-NNA were additive, amounting to 75 +/- 3% inhibition. The effect of L-NNA reflected inhibition of NO release from nerve terminals, as well as NO generation in muscle cells by the action of VIP and PACAP; the effect of apamin reflected blockade of the action of PACAP. Thus, inhibitory transmission in guinea pig gastric fundus represents the combined actions of VIP, PACAP and NO released from nerve terminals and NO generated in muscle cells. The postjunctional actions of PACAP are mediated by a VIP/PACAP-II receptor and by a PACAP-specific, apamin-sensitive receptor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764352

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Roles of PACAP and PHI as inhibitory neurotransmitters in the circular muscle of mouse antrum.

Authors:  Makiko Toyoshima; Tadayoshi Takeuchi; Hiroto Goto; Kazunori Mukai; Norihito Shintani; Hitoshi Hashimoto; Akemichi Baba; Fumiaki Hata
Journal:  Pflugers Arch       Date:  2005-11-15       Impact factor: 3.657

2.  Central effects of pituitary adenylate cyclase activating polypeptide (PACAP) on gastric motility and emptying in rats.

Authors:  M Ozawa; M Aono; M Moriga
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

3.  Stimulant action of pituitary adenylate cyclase-activating peptide on normal and drug-compromised peristalsis in the guinea-pig intestine.

Authors:  A Heinemann; P Holzer
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

4.  PACAP/PAC1R signaling modulates acetylcholine release at neuronal nicotinic synapses.

Authors:  Phyllis C Pugh; Selwyn S Jayakar; Joseph F Margiotta
Journal:  Mol Cell Neurosci       Date:  2009-12-01       Impact factor: 4.314

5.  The pituitary adenylate cyclase-activating polypeptide is a physiological inhibitor of platelet activation.

Authors:  Kathleen Freson; Hitoshi Hashimoto; Chantal Thys; Christine Wittevrongel; Sophie Danloy; Yoshiko Morita; Norihito Shintani; Yoshiaki Tomiyama; Jos Vermylen; Marc F Hoylaerts; Akemichi Baba; Chris Van Geet
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

6.  Pituitary Adenylate Cyclase-activating Polypeptide Inhibits Pacemaker Activity of Colonic Interstitial Cells of Cajal.

Authors:  Mei Jin Wu; Keun Hong Kee; Jisun Na; Seok Won Kim; Youin Bae; Dong Hoon Shin; Seok Choi; Jae Yeoul Jun; Han-Seong Jeong; Jong-Seong Park
Journal:  Korean J Physiol Pharmacol       Date:  2015-08-20       Impact factor: 2.016

Review 7.  Presence and Effects of Pituitary Adenylate Cyclase Activating Polypeptide Under Physiological and Pathological Conditions in the Stomach.

Authors:  Dora Reglodi; Anita Illes; Balazs Opper; Eszter Schafer; Andrea Tamas; Gabriella Horvath
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-19       Impact factor: 5.555

Review 8.  Adaptive Changes in the Central Control of Energy Homeostasis Occur in Response to Variations in Energy Status.

Authors:  Cassandra Gastelum; Lynnea Perez; Jennifer Hernandez; Nikki Le; Isabella Vahrson; Sarah Sayers; Edward J Wagner
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.